Opportunity
SAM #75N98026Q00647
Support for Youth-Onset Type 2 Diabetes Research Collaboration between CNH and NIDDK
Buyer
NIH Office of Logistics and Acquisition Operations
Posted
June 17, 2026
Respond By
June 29, 2026
Identifier
75N98026Q00647
NAICS
622110, 541715
This opportunity from the Department of Health and Human Services, National Institutes of Health (NIH), Office of Logistics and Acquisition Operations (OLAO), seeks support for a collaborative research protocol focused on youth-onset type 2 diabetes: - Government Buyer: - Department of Health and Human Services (HHS) - National Institutes of Health (NIH) - Office of Logistics and Acquisition Operations (OLAO) - Collaboration between Children’s National Hospital (CNH) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) - Research Protocol Details: - Multi-site longitudinal study investigating metabolic mechanisms of diabetes risk and management in youth and young adults - Focus on progression of youth-onset type 2 diabetes and associated cardiovascular risks - Protocol registered on clinicaltrials.gov (NCT06730113) and has regulatory approval - Services Requested: - Research collaboration and coordination services to facilitate activities between CNH and NIH Clinical Center - Unique Requirements: - No specific products or equipment listed for procurement - Emphasis on regulatory compliance and research collaboration agreement - OEMs and Vendors: - No OEMs or commercial vendors specified; primary collaborators are CNH and NIDDK
Description
Youth-onset type 2 diabetes (T2D) is a rapidly progressive, debilitating disease that is associated with early-onset micro- and macrovascular complications. The rate of disease progression and the natural history of subclinical atherosclerosis in T2D youth remains to be elucidated. The joint CNH/ NIDDK Y-T2DM program investigates metabolic mechanisms of diabetes risk and management in youth, and young adults. We are conducting a multi-site study with Children’s National Hospital as a site to evaluate risk for heart disease and in youth. The protocol is registered on clinicaltrials.gov (NCT06730113) and has received regulatory approval. A research collaboration agreement is being processed to support research activities and coordination between CNH and the National Institutes of Health Clinical Center (NIH CC).